Islet cell antibodies in diabetes mellitus associated with a mitochondrial tRNA(Leu(UUR)) gene mutation

Experimental and Clinical Endocrinology and Diabetes

Volumn 104, Issue 3, 1996, Pages 212-217

  Oexle, K ^a   Oberle, J ^a   Finckh, B ^b   Kohlschutter A ^b   Nagy, M ^a   Seibel, P ^c   Seissler, J ^d   Hubner C ^a  

^a HUMBOLDT UNIVERSITY   (Germany)

^b UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^c UNIVERSITY HOSPITAL WÜRZBURG   (Germany)

^d UNIVERSITY HOSPITAL LEIPZIG   (Germany)

Author keywords

Diabetes mellitus; Islet cell antibodies; MELAS; Mitochondrial encephalomyopathy; Pancreatitis

Indexed keywords

ANTIOXIDANT; MITOCHONDRIAL RNA; PANCREAS ISLET CELL ANTIBODY; TRANSFER RNA;

ADULT; ARTICLE; BRAIN DISEASE; CELL DAMAGE; CLINICAL ARTICLE; FEMALE; GENE MUTATION; HUMAN; HUMAN CELL; IMPAIRED GLUCOSE TOLERANCE; LACTIC ACIDOSIS; MALE; MATERNAL DIABETES MELLITUS; MUSCLE HYPOTONIA; PANCREAS ISLET CELL; PANCREATITIS; PERCEPTION DEAFNESS; POINT MUTATION; PRIORITY JOURNAL; SCHOOL CHILD; SHORT STATURE; STROKE;

EID: 0029898132     PISSN: 09477349     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0029-1211445     Document Type: Article

References (33)

1. Ballinger SW, Shoffner JM, Hedaya EV, Trounce I, Polak MA, Koontz DA, Wallace DC: Maternally transmitted diabetes and deafness associated with a 10.4 kb mitochondrial DNA deletion. Nature Genet 1: 11-15, 1992
2. Bolaffi JL, Rodd GG, Wang J, Grodsky GM: Interrelationship of changes in islet nicotine adeninedinucleotide, insulin secretion, and cell viability induced by interleukin-1β. Endocrinology 134: 537-542, 1994
3. Corbett JA, McDaniel ML: Reversibility of interleukin-1β-induced islet destruction and dysfunction by the inhibition of nitric oxide synthase. Biochem J 299: 719-724, 1994
4. Detimary P, Gilon P, Nenquin M, Henquin J-C: Two sites of glucose control of insulin release with distract dependence on the energy state in pancreatic B-cells. Biochem J 297: 455-461, 1994
5. Dunbar DR, Moonie PA, Swingler RJ, Davidson D, Roberts R, Holt IJ: Maternally transmitted partial direct tandem duplication of mitochondrial DNA associated with diabetes mellitus. Hum Mol Genet 2: 1619-1624, 1993
6. Elliott RB, Chase HP: Prevention or delay of type 1 (insulin-dependent) diabetes mellitus in children using nicotinamide. Diabetologia 34: 362-365, 1991
7. Hirano M, Ricci E, Koenigsberger MR, Defendini R, Pavlakis SG, DeVivo DC, DiMauro S, Rowland LP: MELAS: an original case and clinical criteria for diagnosis. Neuromusc Disord 2: 125-135, 1992
8. Jonsson J, Carlsson L, Edlund T, Edlund H: Insulin-promotor-factor 1 is required for pancreas development in mice. Nature 371: 606-609, 1994
9. Kadowaki T, Kadowaki H, Mori Y, Kazuyuki T, Sakuta R, Suzuki Y, Tanabe Y, Sakura H, Awata T, Goto Y-I, Hayakawa T, Matsuoka K, Kawamori R, Kamada T, Horai S, Nonaka I, Hagura R, Akanuma Y, Yazaki Y: A subtype of diabetes mellitus associated with a mutation of mitochondrial DNA. N Engl J Med 330: 962-968, 1994
10. Kallmann B, Burkart V, Kröncke K-D, Kolb-Bachofen V, Kolb H: Toxicity of chemically generated nitric oxide towards pancreatic islet cells can be prevented by nicotinamide. Life Sci 51: 671-678, 1992
11. Leu(UUR) gene mutation in Japanese patients. Diabetologia 37: 504-510, 1994
12. Kelley GG, Zawalich KC, Zawalich WS: Calcium and a mitochondrial signal interact to stimulate phosphoinositide hydrolysis and insulin secretion in rat islets. Endocrinology 134: 1648-1654, 1994
13. Kobayashi T: Subtype of insulin-dependent diabetes mellitus (IDDM) in Japan: slowly progressive IDDM - the clinical characteristics and pathogenesis of the syndrome. Diabetes Res Clin Pract 24 Suppl.: S95-S99, 1994
14. Kontush A, Hübner C, Finckh B, Kohlschütter A, Beisiegel U: Low density lipoprotein oxidizability by copper correlates to its initial ubiquinoi-10 and polyunsaturated fatty acid content. FEBS Lett 285: 39-43, 1994
15. Oka Y, Katagiri H, Yazaki Y, Murase T, Kobayashi T: Mitochondrial gene mutation in islet-cell-antibody-positive patients who were initially non-insulin-dependent diabetics. Lancet 342: 527-528, 1993
16. Leu(UUR) gene in a large pedigree with maternally transmitted type II diabetes mellitus and deafness. Nature Genet 1: 368-371, 1992
17. 31P magnetic resonance spectroscopy during treatment with nicotinamide and riboflavin. Neurology 42: 2147-2152, 1992
18. Piccolo G, Banfi P, Azan G, Rizzuto R, Bisson R, Sandoná D, Bellomo G: Biological markers of oxidative stress in mitochondrial myopathies with progressive external ophthalmoplegia. J Neurol Sci 105: 57-60, 1991
19. Ronningen KS, Spurkland A, Tait BD, Drummond B, Lopez-Larrea C, Baranda FS et al.: HLA class II associations in insulin-dependent diabetes mellitus among Blacks, Caucasoids, and Japanese. In: Tsuji K, Aizawa M, Sasazuki T (editors). HLA 1991. Proceedings of the eleventh workshop, pp. 713-722, Oxford University Press, New York, 1992
20. Reardon W, Ross RJM, Sweeney MG, Luxon LM, Pembrey ME, Harding AE, Trembath RC: Diabetes mellitus associated with a pathogenic point mutation in mitochondrial DNA. Lancet 340: 1376-1379, 1992
21. Roewer L, Nagy M, Schmidt P, Epplen JT, Herzog-Schröder G: Microsatellite and HLA class II oligonucleotide typing in a population of Yanomani Indians. In: Pena SDJ, Chakraborty R, Epplen JT, Jeffreys AJ (editors). DNA fingerprinting: state of science, pp 221-230, Birkhäuser, Basel, 1993
22. Schulz JB, Klockgether T, Dichgans J, Seibel P, Reichmann H: Mitochondrial gene mutations and diabetes mellitus. Lancet 341: 438-439, 1993
23. Seibel P, Flierl A, Kottlors M, Reichmann H: A rapid and sensitive PCR screening method for point mutations associated with mitochondrial encephalomyopathies. Biochem Biophys Res Commun 200: 938-942, 1994
24. Seissler J, Amann J, Mauch L, Haubruck H, Wolfahrt S, Bieg S, Richter W, Holl R, Heinze E, Northemann W, Scherbaum WA: Prevalence of autoantibodies to the 65- and 67-kD isoforms of glutamate decarboxy- lase in insulin-dependent diabetes mellitus. J Clin Invest 92: 1394-1399, 1993
25. Shoffher JM, Wallace DC: Oxidative phosphorylation diseases. In: Scriver CR, Beaudet AL, Sly WS, Valle D (editors). The metabolic and molecular bases of inherited disease, 7th Edition, pp. 1535-1609, McGraw-Hill, New York, 1995
26. Leu(UUR) gene: a study in seven families with mitochondrial encephalomyopathy, lactic acidosis and stroke-like episodes (MELAS). Diabetologia 37: 818-825, 1994a
27. LYS mutation. Diabetes Care 17: 1428-1433, 1994b
28. Thurnham DI, Situnayake RD, Koottathep S, McConkey B, Davies M: Antioxidant status measured by the TRAP' assay in rheumatoid arthritis. In: Rice Evans C (editor). Free radicals, oxidant stress and drug action, pp. 169-192, Richelieu Press, London, 1987
29. Todd JA, Bell JI, McDevitt HO: HLA-DQβ gene contributes to susceptibility and resistance to insulin-dependent diabetes mellitus. Nature 329: 599-604, 1987
30. Unger RH, Foster DW: Diabetes mellitus. In: Wilson JD, Foster DW (editors). Williams textbook of endocrinology, 8th Edition, pp. 1255-1333, W. B. Saunders, Philadelphia, 1992
31. Vionnet N, Passa P, Froguel P: Prevalence of mitochondrial gene mutations in families with diabetes mellitus. Lancet 342: 1429-1430, 1993
32. de Vries D, de Wijs I, Ruitenbeek W, Begeer J, Smit P, Bentlage H, van Oost B: Extreme variability of clinical symptoms among sibs in a MELAS family correlated with heteroplasmy for the mitochondrial A3243G mutation. J Neurol Sci 124: 77-82
33. Zhang J, Dawson VL, Dawson TM, Snyder SH: Nitric oxide activation of poly(ADP-ribose) synthetase in neurotoxicity. Science 263: 687-689, 1994